1 Value Stock Worth Your Attention and 2 Facing Challenges

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Separating the winners from the value traps is a tough challenge, and that’s where StockStory comes in. Our job is to find you high-quality companies that will stand the test of time. Keeping that in mind, here is one value stock trading at a big discount to its intrinsic value and two with little support.

Two Value Stocks to Sell:

Caleres (CAL)

Forward P/E Ratio: 9.3x

The owner of Dr. Scholl's, Caleres (NYSE:CAL) is a footwear company offering a range of styles.

Why Do We Pass on CAL?

1. Annual revenue growth of 5.4% over the last five years was below our standards for the consumer discretionary sector
2. Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
3. High net-debt-to-EBITDA ratio of 8× could force the company to raise capital on unfavorable terms if market conditions deteriorate

Caleres is trading at $14.92 per share, or 9.3x forward P/E. Dive into our free research report to see why there are better opportunities than CAL.

Addus HomeCare (ADUS)

Forward P/E Ratio: 13.3x

Serving approximately 66,000 clients across 22 states with a focus on "dual eligible" Medicare and Medicaid beneficiaries, Addus HomeCare (NASDAQ:ADUS) provides in-home personal care, hospice, and home health services to elderly, chronically ill, and disabled individuals.

Why Is ADUS Not Exciting?

1. Revenue base of $1.45 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale

Addus HomeCare’s stock price of $91.68 implies a valuation ratio of 13.3x forward P/E. Check out our free in-depth research report to learn more about why ADUS doesn’t pass our bar.

One Value Stock to Buy:

Abercrombie and Fitch (ANF)

Forward P/E Ratio: 7.5x

Founded as an outdoor and sporting brand, Abercrombie & Fitch (NYSE:ANF) evolved to become a specialty retailer that sells its own brand of fashionable clothing to young adults.

Why Do We Love ANF?

1. Comparable store sales rose by 7.3% on average over the past two years, demonstrating its ability to drive increased spending at existing locations
2. Differentiated product assortment is reflected in its best-in-class gross margin of 62.4%
3. Performance over the past three years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue

At $77.09 per share, Abercrombie and Fitch trades at 7.5x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

Stocks We Like Even More

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.